Zhao et al. [164] used a PET imaging system with a new diagnostic radiopharmaceutical to present a quantitative analysis of tau accumulation in healthy, older adults, mild cognitive impairment, and AD patients [164]. Here, MAPT is linked to Alzheimer disease.